BUE Equity Snapshot

BMY Weekly Equity Report

Bristol-Myers Squibb Company

Interactive chart JSON snapshot
Latest Close 28,360 ARS 12 Jun 2026
1W Return -1.6% latest completed week
4W Return 0.7% short-term follow-through
12W Return 0.9% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
Company Brief

What the company does

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive …

Snapshot

What the weekly tape is saying

BMY closed the latest completed week at 28,360 ARS. The 4-week return is 0.7% and the 12-week return is 0.9%. Trend Signal is active, Market Dynamics is -0.78. Setup signature: Balanced read with a 42/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 0.1%
Volume 0.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 83 Persistence of active Trend Signal over the last year and current streak.
Momentum 52 Blend of 4-week and 12-week follow-through.
Dynamics 35 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 15 Participation compared with the 13-week volume baseline.
Risk Control 66 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
28,330 ARS
Vs Trend Line
0.1%
Fair Value
20,980 ARS
Vs Fair Value
35.2%
52W High
30,900 ARS
52W Low
18,049 ARS
Drawdown
-8.2%
Range Position
80.2%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.6%
4W 0.7%
12W 0.9%
26W 7.3%
52W 43.6%

Trend read

Active Streak
36 weeks
52W Active Weeks
36
52W Active Breadth
69.2%
Sector Scope
AR Healthcare
Sector Rank
14 of 20
Sector Percentile
31.6%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.78
4W MD Change
-12.8%
Relative Strength
-14.63
4W RS Change
-367.0%
Expectation
Positive
Probability
57.84%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.6K
13W Average
4.7K
52W Average
5.3K
Vs 13W
0.3x
Vs 52W
0.3x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.9%
52W Volatility
3.9%
Upside Weeks
31
Downside Weeks
21
Downside Breadth
40.4%
Avg Gain / Loss
3.3% / -3.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
ARS
Market Cap
55707.7B

Opportunity signals

  • Trend Signal is active with a 36-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 28,360 ARS -1.6% 28,330 ARS 20,980 ARS -0.78 -14.63 1.6K On
5 Jun 2026 28,820 ARS 2.3% 28,161 ARS 20,870 ARS -0.75 -5.85 18.4K On
29 May 2026 28,160 ARS -4.6% 27,965 ARS 20,754 ARS -0.86 -10.32 2.9K On
22 May 2026 29,520 ARS 4.8% 27,798 ARS 20,644 ARS -0.66 4.67 3.9K On
15 May 2026 28,160 ARS 1.4% 27,575 ARS 20,523 ARS -0.69 5.48 4.0K On
8 May 2026 27,780 ARS -8.2% 27,386 ARS 20,412 ARS -0.64 2.26 3.0K On
1 May 2026 30,260 ARS 3.3% 27,190 ARS 20,302 ARS -0.46 9.22 4.4K On
24 Apr 2026 29,300 ARS -0.2% 26,952 ARS 20,175 ARS -0.51 5.72 1.4K On
17 Apr 2026 29,360 ARS 2.2% 26,695 ARS 20,052 ARS -0.52 4.52 1.6K On
10 Apr 2026 28,720 ARS -5.1% 26,498 ARS 19,932 ARS -0.53 -1.23 13.3K On
3 Apr 2026 30,260 ARS 5.3% 26,301 ARS 19,808 ARS -0.59 3.95 1.9K On
27 Mar 2026 28,740 ARS 2.2% 26,017 ARS 19,674 ARS -0.40 5.65 1.4K On
20 Mar 2026 28,120 ARS -2.5% 25,770 ARS 19,550 ARS 0.09 5.82 3.1K On
13 Mar 2026 28,840 ARS -2.4% 25,539 ARS 19,426 ARS 0.50 11.83 1.9K On